James Goodrich

Maraviroc for Previously Treated Patients with R5 HIV-1 Infection

Roy M. Gulick, Jacob Lalezari, James Goodrich et al. · New England Journal of Medicine · 2008 · 741 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Molecular and Clinical Epidemiology of CXCR4‐Using HIV‐1 in a Large Population of Antiretroviral‐Naive Individuals

Zabrina L. Brumme, James Goodrich, Howard Mayer et al. · The Journal of Infectious Diseases · 2005 · 270 citations · Full text

Public Health, Immunology, Infectious Diseases +9

Maraviroc versus Efavirenz, Both in Combination with Zidovudine‐Lamivudine, for the Treatment of Antiretroviral‐Naive Subjects with CCR5‐Tropic HIV‐1 Infection

David A. Cooper, Jayvant Heera, James Goodrich et al. · The Journal of Infectious Diseases · 2010 · 265 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

Itraconazole treatment of phaeohyphomycosis

P. K. Sharkey, John R. Graybill, Michael G. Rinaldi et al. · Journal of the American Academy of Dermatology · 1990 · 212 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +12

Ixmyelocel-T for patients with ischaemic heart failure: a prospective randomised double-blind trial

Amit N. Patel, Timothy D. Henry, Arshed A. Quyyumi et al. · The Lancet · 2016 · 171 citations

Medicine, Cardiology, Internal Medicine +6